Correction of a genetic disease in mouse via use of CRISPR-Cas9. - Wikidata - awgldk - TriplyDB

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

http://www.wikidata.org/entity/Q34658184

about

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseases CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases Customizing the genome as therapy for the β-hemoglobinopathies The Rise of CRISPR/Cas for Genome Editing in Stem Cells Genome-editing Technologies for Gene and Cell Therapy Genome Editing and Its Applications in Model Organisms Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools Oligonucleotide-directed mutagenesis for precision gene editing Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases Breaking bad: The mutagenic effect of DNA repair Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation Survival and Evolution of CRISPR-Cas System in Prokaryotes and Its Applications The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases Therapeutic genome editing: prospects and challenges Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment Development and applications of CRISPR-Cas9 for genome engineering.CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.Decoding the complex genetic causes of heart diseases using systems biology Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo A class of circadian long non-coding RNAs mark enhancers modulating long-range circadian gene regulation.Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells.Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs.CRISPR/Cas9 in allergic and immunologic diseases.Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac.Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage.A CRISPR view of development.CRISPR-mediated direct mutation of cancer genes in the mouse liver TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery.CRISPR-based technologies: prokaryotic defense weapons repurposed Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA A mouse geneticist's practical guide to CRISPR applications.

P2860

Q22337358-2D6E0AAE-F6C8-4FA4-B8A4-A90F49DD07E8 Q26744780-11FB9F12-1FB6-4C72-8989-1546FE5DD0C1 Q26747564-E36D9609-F639-48DE-AAD7-75E5B606070C Q26751061-C32A50E6-DDDB-4AFA-BE80-E2DACB5A7878 Q26765852-232A2122-37DA-475A-A6D2-EA9C1CB283AB Q26769662-24FD7585-D40F-4634-8CDA-1E4EE6048037 Q26772108-99E3FEBC-F01C-41B4-A56F-8524DBFA8E2B Q26777286-A63B6554-8228-47EE-93CF-73B46B5C45B4 Q26778792-F9FF3D35-68DE-4DEE-A9A0-1227F5C9996A Q26778992-64C0370C-2257-405A-9D3E-097CF6533503 Q26827700-707F9661-89AA-41B4-8E0F-8A539F896B87 Q26852489-6F3B8358-E912-439A-B282-C26DBBA7D741 Q27025675-22EE0329-763D-4D20-970F-18765DBBC88A Q27339934-B96D454C-89D3-4AC1-89D6-372B7094C969 Q28079111-8C33B4DF-03B0-44DE-9EEC-52B95B3D162F Q28085767-E5FB19D9-DDF9-4C7B-A211-34BAA4CFC8EC Q28087380-A40A97FB-6B39-49AD-8DB1-6EA359066A39 Q28087526-E53B6118-58AF-463D-A7D9-E1BE77B4CA37 Q28241526-28D18723-E17E-4C17-8EF1-535D2B6B3ED2 Q30725695-D2BEA6D1-7326-45FB-A698-1B1EA9F320AA Q33558467-56625C84-DF70-45A5-89D2-A009C2BD0105 Q33639681-85953A37-61EE-4F77-B6E1-78254C45DE88 Q33648073-8E69603A-0E62-4492-B655-D5ADB28EA01E Q33652566-4D52BBEC-40FF-4BA7-93C9-E4FA9D91C19B Q33741010-08ED7C04-DC31-46E6-B10B-75343F01313C Q33791002-34F6321B-745D-4BDB-8BF4-ABC5F7737DC3 Q33851650-281E0669-1FD1-4DAD-AA10-824AB89FDF59 Q33985245-6C3861C0-B856-483A-BD2C-9C6F50E92727 Q34040385-DD5D005B-5AFF-4939-A180-97FDD9C39ED2 Q34043553-345948AF-A12B-4D4F-AC37-01E0B48A8E69 Q34047460-624997B9-AB2F-4554-ACB4-B661A76FE091 Q34093413-2330BE1F-E89D-4F0D-86A6-F3ECD4B4CB32 Q34153816-9EE9D467-E71F-4F3B-8BDD-6B306900CAED Q34282392-6937D759-EB79-4776-AFDD-E6E6B8FE2960 Q34342877-61C15049-D8B4-49B9-80E6-69D02BC5F9FA Q34353586-B5360E5E-1791-42A3-9CE2-30E56C86E7FE Q34394269-84C7DF7C-29B0-4677-8512-A0864BAAA60B Q34405661-0678898C-D2D8-468F-B142-F91ADD514BC2 Q34433586-C76772CA-729C-4BF3-9B6E-ECC6F4FE732B Q34441174-6A9D0132-F4CD-46F1-8614-D322A781DDC2

P2860

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

http://www.wikidata.org/entity/Q34658184

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@ast

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@en

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@nl

type

label

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@ast

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@en

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@nl

prefLabel

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@ast

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@en

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@nl

P1433

Q34658184-10EBCB72-CE71-49E0-9C6A-E47700AD01BB

P1476

Q34658184-447CBA0C-6620-47BF-A171-A6DEE8EBFE39

P2093

Q34658184-5A7C635F-42DD-4811-B53A-02FD05D1C35E

Q34658184-5B4A9E1F-8958-4F2B-8429-3ABCDEAD2B4D

Q34658184-63B1110F-CCAC-4DF1-A3B3-06DD2005DD52

Q34658184-7DD5A880-3325-44C2-8690-78651D759E87

Q34658184-A54A5BCB-2019-4757-8A9C-41055CC4FFC3

Q34658184-BF6056E7-53B5-441B-9E25-ADA6EC0C9AC0

Q34658184-CBA07094-3379-44FB-8952-4D84CB90063F

Q34658184-D1207E6C-01B5-4890-B2A0-421C14CBF667

Q34658184-E49EF5A6-76FC-47E0-BFB0-8E6E574146CD

P304

Q34658184-4ADB20AE-C725-4103-8067-E364A4454CA3

P31

Q34658184-F3C3CB01-D7B4-49AE-9E4A-2B4CDA36AA9B

P356

Q34658184-948C76C5-3E91-4C21-BD93-C3F959F2451D

P407

Q34658184-5D96A3A9-2BF6-4B58-AC6A-541BA0EAE978

P433

Q34658184-630C5ACA-1D37-442D-9547-331C30F7F151

P478

Q34658184-F352B23C-5EA2-4539-9C4E-CC238E7CF984

P577

Q34658184-B95C0CDC-C694-446E-B3CE-AF98D48C4160

P5875

Q34658184-2473F5FD-7C81-492C-9370-3620B8FB21DF

P698

Q34658184-EED2876F-FDF3-417B-B1DC-38FD4D28E2DF

P921

Q34658184-EC631B52-B2F1-4912-999E-5890D597E5F5

P356

J.STEM.2013.10.016

P1433

P1476

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

@en

P2093

Dan Liang

http://www.w3.org/2001/XMLSchema#string

Dangsheng Li

http://www.w3.org/2001/XMLSchema#string

Jinsong Li

http://www.w3.org/2001/XMLSchema#string

Meizhu Bai

http://www.w3.org/2001/XMLSchema#string

Shiming Bao

http://www.w3.org/2001/XMLSchema#string

Wei Tang

http://www.w3.org/2001/XMLSchema#string

Yinghua Wang

http://www.w3.org/2001/XMLSchema#string

Yuxuan Wu

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Yan

http://www.w3.org/2001/XMLSchema#string

P304

659-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEM.2013.10.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259245304

http://www.w3.org/2001/XMLSchema#string

P698

24315440

http://www.w3.org/2001/XMLSchema#string

P921